MIRA INFORM REPORT
|
Report Date : |
26.05.2011 |
IDENTIFICATION DETAILS
|
Name : |
ABBOTT LABORATORIES |
|
|
|
|
Registered Office : |
100 Abbott Park Road, Abbott Park, IL 60064-6400 |
|
|
|
|
Country : |
United States |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
06.03.1900 |
|
|
|
|
Legal Form : |
Corporation for Profit |
|
|
|
|
Line of Business : |
Health care products manufacturing |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 3,000,000 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Regular |
|
Litigation : |
Exists |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
United States |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GEOPOLITCS - UNITED STATES
|
POLITICAL DATA |
ECONOMIC DATA |
|
|
Form of Government: Federal
|
Currency: USD |
IDENTIFICATION
|
Ordered as: |
Abbott Laboratories |
|||
|
Address in the order: |
Dept. 36M, 200 Abbott Park Road, Abbottr Park, IL 60064 3537 |
|||
|
Comments on data supplied: |
Dear Client, the address provided in the order is that of a location
that the company opeates. The company is in fact headquartered at the address
listed below. |
|||
|
Legal Name: |
ABBOTT LABORATORIES |
|||
|
Legal Address |
100 Abbott Park Road, Abbott Park, IL 60064-6400, United States |
|||
|
|
|
|||
|
Telephone: |
847-937-6100 |
ID : |
08142220 |
|
|
Fax: |
847-937-1511 |
Legal Form: |
Corporation for Profit |
|
|
Email: |
Registered in: |
Illinois |
||
|
Website: |
Date Created: |
1888 |
||
|
Manager: |
Miles D. White, Chief Executive Officer |
Date Incorporated: |
March 6th, 1900 |
|
|
Staff: |
90,000 |
Stock: |
1,547,581,805 |
|
|
|
|
Value: |
$69,683,328,714 |
|
|
Activity: |
Health care products manufacturing |
|||
BANKS
|
Name of the Bank |
CITIBANK |
BUSINESS
|
HISTORY |
||
|
|
The company was created in 1888. |
|
|
PRINCIPAL ACTIVITY |
||
|
|
Health care products manufacturing |
|
|
Products/Services description: |
||
|
|
Abbott Laboratories engages in the discovery, development,
manufacture, and sale of health care products worldwide. It operates in four
segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products,
and Vascular Products. |
|
|
Sales are: |
||
|
|
Wholesale |
|
|
Brands: |
||
|
|
Ensure®, Ensure Plus®, Ensure® Muscle Health, Glucerna®, ProSure™,
PediaSure®, PediaSure Sidekicks®, EleCare®, Juven®, Abound™, Pedialyte®,
imilac®Advance®, Similac Advance EarlyShield®, Similac®, Similac® with Iron,
Similac Sensitive®, Similac Sensitive® RS, Similac Go&Grow®, Similac®
NeoSure®, Similac® Organic, Similac® Special Care®, Isomil® Advance®,
Isomil®, Alimentum®, Gain™, and Grow™; etc |
|
|
Clients: |
||
|
|
Professionals of the industry. |
|
|
Operations area: |
||
|
|
National, International |
|
|
The company imports from worldwide. |
||
|
The company export to worldwide. |
||
|
Trade References: |
||
|
|
We could not contact any representative of the subject that could provide
us the names of their suppliers for us to check trade references. |
|
|
The subject employs 90,000 employee(s) |
||
|
PAYMENTS |
||
|
|
regular |
|
|
LOCATION |
||
|
Headquarters |
||
|
|
The company is headquartered at: 100 Abbott Park Road, Abbott Park, IL 60064-6400, United States |
|
|
Branches: |
||
|
|
The company has several other locations in the USA, including the
address provided in the order. |
|
|
Business Overview: |
||
|
|
Demand is driven by population demographics and advances in medical
knowledge and technology. The profitability of individual companies depends
on the ability to develop superior products. Large companies have economies
of scale in manufacturing and R&D. Small companies can compete
successfully by specializing in a particular market segment, or through
technical innovation. |
|
Shareholders - Manager - Related Companies
|
Listed at the stock exchange: |
||
|
|
YES |
|
|
Capital: |
||
|
|
% of Shares Held by All Insider and 5% Owners: 0% % of Shares Held by Institutional & Mutual Fund Owners: 66% % of Float Held by Institutional & Mutual Fund Owners: 67% Number of Institutions Holding Shares:1416 |
|
|
Shareholders Parent Company(ies): |
||
|
|
Major Direct Holders White Miles D Freyman Thomas C Ashley Richard W Michael Edward L Capek John M Top Institutional Holders Vanguard Group, Inc. (The) State Street Corporation Capital Research Global Investors Blackrock Institutional Trust Company, N.A. Jp Morgan Chase & Company Bank Of New York Mellon Corporation Northern Trust Corporation Massachusetts Financial Services Co - Other Wellington Management Company, Llp Bank Of America Corporation Top Mutual Fund Holders Investment Company Of America Vanguard Total Stock Market Index Fund Vanguard Specialized-Health Care Fund Vanguard 500 Index Fund Vanguard Institutional Index Fund-Institutional Index Fd Spdr S&P 500 Etf Trust American Mutual Fund Inc Capital Income Builder, Inc. Fidelity Contrafund Inc Gmo Quality Fund |
|
|
Management: |
||
|
|
Board of Directors: Robert J. Alpern, M.D. Roxanne S. Austin W. James Farrell H. Laurance Fuller Edward M. Liddy Phebe N. Novakovic William A. Osborn Samuel C. Scott III Glenn F. Tilton Miles D. White Management: Miles D. White, Chairman Of The Board And Chief Executive Officer Thomas C. Freyman, Executive Vice President, Finance And Chief
Financial Officer Greg W. Linder, Vice President And Controller |
|
|
Related Companies: |
||
|
|
ABBOTT ADMINISTRATION INC. ABBOTT BIOLOGICALS, LLC ABBOTT BIORESEARCH CENTER, INC. ABBOTT BIOTECH VENTURES INC. ABBOTT BIOTHERAPEUTICS CORP. ABBOTT CARDIOVASCULAR INC. ABBOTT CARDIOVASCULAR SYSTEMS INC. ABBOTT DELAWARE INC. ABBOTT DIABETES CARE INC. ABBOTT DIABETES CARE SALES CORPORATION ABBOTT ENDOCRINE INC. ABBOTT ENDOCRINOLOGY INC. ABBOTT EQUITY INVESTMENTS LLC ABBOTT EXCHANGE INC. ABBOTT HEALTH PRODUCTS, INC. ABBOTT HOME INFUSION SERVICES OF NEW YORK, INC. ABBOTT INTERNATIONAL LLC ABBOTT INVESTMENTS HOLDINGS CORPORATION Among many others... |
|
Financials - COMMERCIAL TRENDS AND FORECAST
|
The subject is a public company traded at
the NYSE:ABT. Please find enclosed the financial
statements. |
|
|
Legal Fillings |
|
|
There are several UCC** files listed with
the Secretary of State of Illinois. The company is subject to various legal
proceedings and claims that arise in the ordinary course of their business.
Although the outcome of these other claims cannot be predicted with
certainty, management does not believe that the ultimate resolution of these
matters will have a material adverse effect on the financial condition or
results of operations The last annual report was filed on
2/18/2011 THE COMPANY IS NOT LISTED ON THE OFAC
LIST.* For information: * The Specially Designated Nationals (SDN)
List is a publication of OFAC which lists individuals and organizations with
whom United States citizens and permanent residents are prohibited from doing
business. ** The Uniform Commercial Code (UCC) is
one of a number of uniform acts that have been promulgated in conjunction
with efforts to harmonize the law of sales and other commercial transactions
in all 50 states within the United States of America. The UCC deals primarily with transactions
involving personal property (movable property), not real property (immovable
property). It allows a creditor to notify other
creditors about a debtor’s assets used as collateral for a secured
transaction by filing a public notice (financing statement) with a particular
filing office. The Uniform Commercial Code Bureau files
and maintains on financial obligations (including IRS liens) incurred by
individuals (in business as a sole proprietor), business entities and
corporations. |
Rating
|
Local credit bureau gave a correct credit
rate. The company is in Good Standing. This means that all local and federal
taxes were paid on due date. |
||
|
Final Opinion |
||
|
|
This is a large sized American company,
which employs 90,000 people and has 123 years of experience in the market. It is a well established business, with
good financial structure. A credit line may be considered for USD
3,000,000 |
|
SUMMARY
|
|
|
|||
|
Profitability |
VERY GOOD |
Public Records |
YES |
|
|
Indebtedness |
CONTROLLED |
Payments |
REGULAR |
|
|
Cash |
NORMAL |
|
|
|
APPENDIX
|
Comments |
||
|
|
We called the company but we were transferred into the Accounts
Payable Voicemail. We left a message explaining the reason for our calling but
nobody has called us back yet. |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.38 |
|
UK Pound |
1 |
Rs.73.31 |
|
Euro |
1 |
Rs.63.70 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.